- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced Polycythemia
Total 6021 results
-
Fondazione per la Ricerca Ospedale MaggioreCompletedPolycythemia Vera | Essential Thrombocythemia | MyelofibrosisIsrael, United Kingdom, Czechia, Germany, Italy, Spain
-
Incyte CorporationRecruitingMyelofibrosis | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Myelodysplastic/Myeloproliferative Neoplasm Overlap Syndrome | Relapsed or Refractory Primary Myelofibrosis | Secondary Myelofibrosis (Post-Polycythemia Vera Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis) | ET...United States, Spain, Japan, Italy, Finland, United Kingdom, Canada
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI); Myeloproliferative Disorders-Research ConsortiumCompletedPolycythemia Vera | Essential Thrombocythemia | Myelofibrosis | Idiopathic Myelofibrosis | Myeloproliferative DiseaseUnited States, Canada, Italy, United Kingdom
-
Shandong UniversityWithdrawnMyeloproliferative Disorders | Polycythemia Vera | Essential Thrombocythemia | Myelofibrosis | Chronic Myeloid LeukemiaChina
-
PfizerTerminatedAdvanced Solid Tumors | Advanced CancerUnited States
-
Baxalta now part of ShireCTI BioPharmaWithdrawn
-
University of Colorado, DenverUniversidad Peruana Cayetano Heredia; Jackson, Brian, M.S.; Thomas H Maren FoundationCompletedErythrocytosis | Mountain SicknessPeru
-
STORM Therapeutics LTDRecruitingCancer | Advanced Solid Tumor | Advanced CancerUnited States
-
Millennium Pharmaceuticals, Inc.CompletedAdvanced Solid Tumors, Neoplasms, Advanced SolidHungary
-
AstraZenecaCompletedAdvanced Solid Tumor | Advanced Solid MalignancyJapan
-
Merck Sharp & Dohme LLCCompletedAdvanced Cancer Relapsed | Advanced Cancer Refractory
-
Vividion Therapeutics, Inc.RecruitingAdvanced Solid Tumors | Advanced Hematologic TumorsUnited States, Australia
-
Zhuhai Yufan Biotechnologies Co., LtdRecruitingAdvanced Solid Tumor | Advanced Solid MalignanciesChina
-
Zhuhai Yufan Biotechnologies Co., LtdRecruitingAdvanced Solid Tumor | Advanced Solid MalignanciesUnited States
-
National Cancer Institute (NCI)CompletedPrimary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Chronic Myelomonocytic LeukemiaUnited States
-
Novartis PharmaceuticalsCompletedMyelofibrosisFrance, United Kingdom, Belgium, Germany, Netherlands, Italy, Austria, Spain, Sweden
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingPolycythemia Vera | Essential Thrombocythemia | Myelofibrosis | Myelodysplastic Syndrome | Clonal Cytopenia of Undetermined SignificanceUnited States
-
BiOneCure Therapeutics Inc.RecruitingCancer | Advanced Solid Tumor | Advanced Cancer | OncologyUnited States
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)CompletedAdvanced Malignant Neoplasm | Locally Advanced Malignant NeoplasmUnited States
-
AstraZenecaTerminatedCancer | Advanced Solid Tumors | Advanced Solid MalignanciesUnited States
-
Teon Therapeutics, Inc.Merck Sharp & Dohme LLCTerminatedCancer | Advanced Solid Tumor | Advanced Cancer | OncologyUnited States
-
Zhejiang UniversityRecruitingAdvanced Colorectal Cancer | Advanced Hepatocellular Carcinoma | Advanced Gastric Cancer | Advanced Pancreatic CancerChina
-
Advanced Integrative Medical Science InstituteRecruitingNeoplasms | Advanced Solid Tumor | Advanced Cancer | Oncology | Neoplasm MalignantUnited States
-
AmMax Bio, Inc.CompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
AmgenCompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
Agenus Inc.CompletedAdvanced Solid Cancers | Advanced Solid Cancers Refractory to PD-1United States
-
AmgenCompletedCancer | Advanced Solid Tumors | Solid Tumors | Tumors | Advanced MalignancyUnited States, Australia
-
NantCell, Inc.CompletedQUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid TumorsCancer | Advanced Solid Tumors | Solid Tumors | Tumors | Advanced Malignancy
-
Targeted Medical PharmaUnknownAnemia of Chronic DiseaseUnited States
-
Novartis PharmaceuticalsRecruitingContinued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid MalignanciesSpain, Taiwan, United States, Singapore, France
-
AmgenCompletedCancer | Advanced Solid Tumors | Oncology | Tumors | Advanced Malignancy | Oncology PatientsUnited States
-
Regeneron PharmaceuticalsSanofiCompletedAdvanced Cancer | Advanced MalignanciesUnited States, Spain, Australia
-
Shanghai Miracogen Inc.RecruitingAdvanced Solid Tumors | Advanced or Metastatic Gastric Cancer | Advanced or Metastatic Gastroesophageal Junction CancerUnited States
-
TargeGenCompleted
-
University of CincinnatiNot yet recruitingCancer | Metastatic Cancer | Locally Advanced Solid Tumor | Locally Advanced | Locally Advanced CarcinomaUnited States
-
Chipscreen Biosciences, Ltd.Recruiting
-
Biotheus Inc.RecruitingAdvanced TumorChina
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
Biotheus Inc.Recruiting
-
Shanghai Junshi Bioscience Co., Ltd.Recruiting
-
University Health Network, TorontoUniversity of UlmRecruiting
-
Bristol-Myers SquibbActive, not recruitingAdvanced CancerFrance, United States, Spain, Canada, Argentina, Chile, Italy
-
Bristol-Myers SquibbTerminatedAdvanced CancerUnited States, Netherlands, Australia, Belgium, Canada, Italy, United Kingdom
-
Merck Sharp & Dohme LLCCompleted
-
Coordination Pharmaceuticals, Inc.Completed
-
Peter MacCallum Cancer Centre, AustraliaCompleted
-
OnxeoCompletedAdvanced CancerFrance, Belgium
-
Bristol-Myers SquibbCompleted
-
Case Comprehensive Cancer CenterCompleted
-
Bristol-Myers SquibbCompletedAdvanced CancerUnited States, Canada, Italy, Netherlands, Spain, Israel